Optimized protocol for efficient transfection of dendritic cells without cell maturation

Journal of Visualized Experiments

Volumn , Issue 53, 2011, Pages

  Bowle, Robert ^a   Patil, Sonali ^a   Pincas, Hanna ^a   Sealfon, Stuart C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; High throughput; Immunology; Interferon signaling; Issue 53; Nucleofection; siRNA

Indexed keywords

EID: 80355131618     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2766     Document Type: Article

References (19)

1. Reis e Sousa, C. Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 16: 21-25 (2004).
2. Bancherau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
3. Clark, G.J. et al. The role of dendritic cells in the innate immune system. Microbes Infect. 2, 257-272 (2000).
4. Hamm, A. et al. Efficient transfection method for primary cells. Tissue Eng 8 (2), 235-245 (2002).
5. Henderson, R.A. et al. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res. 56, 3763-3770 (1996).
6. Reeves, M.E. et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56, 5672-5677 (1996).
7. Aicher et al. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 25, 39-44 (1997).
8. Thomas, C.E. et al. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 4 (5), 346-358 (2003).
9. Jooss, K. et al. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212-4223 (1998).
10. Mitchell, D.A. et al. RNA-transfected dendritic cells in cancer immunotherapy. J. Clin. Invest. 106, 1065-1069 (2000).
11. Mincheff, M. et al. In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer-changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile. Crit. Rev. Oncol. Hematol. 39, 125-132 (2001).
12. Roth, M.D. et al. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses. J. Immunol. 169, 4651-4656 (2002).
13. Van Tendeloo, V.F. et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98, 49-56 (2001).
14. Lenz, P. et al. Nucleoporation of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells. FEBS Lett. 538, 149-154 (2003).
15. Prechtel, A.T. et al. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation. J. Immunol. Methods 311, 139-152 (2006).
16. Bowles, R. et al. Validation of efficient high-throughput plasmid and siRNA transfection of human monocyte-derived dendritic cells without cell maturation. J. Immunol. Methods, in press.
17. Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19-28 (2005).
18. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
19. Haller, O. et al. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect. 9, 1636-1643 (2007).